UNSPSC 51361920: Secobarbital

This classification denotes a barbiturate with the molecular formula C12H18N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1P7H87IN75, chemically known as 2,4,6 (1h,3h,5h)-pyrimidinetrione, 5-(1-methylbutyl)-5-(2-propenyl)-, monosodium salt but generally known as secobarbital, which bears US NIH Compound Identifier 5193. European Medicines Agency schedules Secobarbital in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10468MIG.

UNSPSC 51361920 Secobarbital is a Commodity code, but the recent state and local opportunities posted under it do not involve secobarbital procurement; instead, they reflect broader pharmaceutical and health-related product sourcing that state and local agencies are actually conducting. Seminole County, Florida solicited naloxone and drug deactivation systems through an IFB process, while the Texas Health and Human Services Commission issued an RFI exploring direct-to-manufacturer prescription programs, and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) released an RFP for generic multi-source pharmaceuticals and OTC products distributed through authorized wholesalers. The mismatch between the code's specific drug designation and the actual scope of recent opportunities suggests that this Commodity code sees little relevant recent activity in the state and local market, or that tagging practices may not align closely with the specific pharmaceutical products being procured.

The issuing bodies span state health agencies, county health departments, and multistate cooperative purchasing entities. Seminole County's procurement emphasized quarterly deliveries to a specific health building with compliance requirements including E-Verify and drug-free workplace certification, with a two-year initial term and one-year renewal option. The Texas HHS RFI (posted April 3, 2026, with response due April 3, 2026) sought vendor capabilities for direct contracting with self-insured employers and state agencies outside traditional PBM and GPO channels. The Minnesota MMCAP RFP (due March 26, 2026) required vendors to work through three authorized wholesalers, submit detailed NDC and product data, and maintain pricing flexibility across multiple net-price and WAC-minus formats, with a two-year initial contract term and performance penalties of $200 to $1,500 per violation. Geographic activity centers on Florida, Texas, and Minnesota participating in cooperative purchasing spanning multiple states including Oregon.